Results 251 to 260 of about 302,269 (383)

Metformin and reduced risk of cancer in diabetic patients

British medical journal, 2005
J. Evans, L. Donnelly, A. Emslie-Smith, D. Alessi, A. Morris   +4 more
semanticscholar   +1 more source

Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population

International Journal of Cancer, EarlyView.
What's new? In recent years, the possible prognostic impact of concomitant medications in patients with cancer treated with immunotherapy combinations has generated increasing interest. This real‐world analysis evaluated the impact of concomitant medications on survival outcomes in patients with advanced biliary tract cancer treated with cisplatin ...
Federica Lo Prinzi, Francesca Salani, Silvia Camera, Mario Domenico Rizzato, Anna Saborowski, Lorenzo Antonuzzo, Federico Rossari, Tomoyuki Satake, Frederik Peeters, Tiziana Pressiani, Jessica Lucchetti, Jin Won Kim, Oluseyi Abidoye, Ilario Giovanni Rapposelli, Chiara Gallio, Stefano Tamberi, Fabian Finkelmeier, Guido Giordano, Pircher Chiara, Hong Jae Chon, Chiara Braconi, Aitzaz Qaisar, Alessandro Pastorino, Florian Castet, Emiliano Tamburini, Changhoon Yoo, Alessandro Parisi, Anna Diana, Mario Scartozzi, Gerald W. Prager, Antonio Avallone, Marta Schirripa, Il Hwan Kim, Lukas Perkhofer, Ester Oneda, Monica Verrico, Nuno Couto, Jorge Adeva, Stephen L. Chan, Gian Paolo Spinelli, Nicola Personeni, Ingrid Garajova, Maria Grazia Rodriquenz, Silvana Leo, Cecilia Melo Alvim, Ricardo Roque, Mariam Grazia Polito, Emanuela Di Giacomo, Giovanni Farinea, Linda Bartalini, Giada Grelli, Antonio De Rosa, Daniele Lavacchi, Masafumi Ikeda, Jeroen Dekervel, Monica Niger, Rita Balsano, Giuseppe Tonini, Minsu Kang, Giulia Tesini, Alessandra Boccaccino, Vera Himmelsbach, Matteo Landriscina, Selma Ahcene Djaballah, Tanios Bekaii‐Saab, Lorenzo Fornaro, Gianluca Masi, Arndt Vogel, Sara Lonardi, Margherita Rimini, Lorenza Rimassa, Andrea Casadei‐Gardini   +71 more
wiley   +1 more source

Locally delivered 1% metformin gel improves periodontal parameters: A systematic review and meta-analysis. [PDF]

Saudi Dent J
Haba KS, Bencze B, Kammerhofer G, Ujpál M, Bányai D, Hermann P, Antal S, Lipták K, Lipták L, Géczi Z, Hegedüs T, Végh Á, Haluszka D, Végh D, Alghamdi H.   +14 more
europepmc   +1 more source

Metformin and the Polycystic Ovary Syndrome [PDF]

, 2001
John E. Nestler
openalex   +1 more source

Rewriting the MASLD‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism

International Journal of Cancer, EarlyView.
Abstract Abnormal epigenetic patterns are crucial for the progression of metabolic‐associated steatotic liver disease (MASLD) and hepatocellular carcinoma (HCC) development. Recent research focused on the interplay between epigenetics and altered metabolic pathways in HCC from MASLD, suggesting that the reversibility of epigenetic changes offers ...
Chiara Aiello, Eric Felli, Teresa Musarra, Lorenzo Nevi, Annamaria Altomare, Jordi Gracia‐Sancho, Andrea Baiocchini, Simone Carotti   +7 more
wiley   +1 more source

Effect of Imeglimin on mitochondrial function in patients with type 2 diabetes mellitus: a prospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Satheesan A, Kumar J, Leela KV, Murugesan R.   +3 more
europepmc   +1 more source

Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.

, 2000
Giovanni Patanè, Salvatore Piro, Agata Maria Rabuazzo, M. Anello, Riccardo Vigneri, Francesco Purrello   +5 more
openalex   +1 more source

The role of UPR‐related long noncoding RNAs in development of endocrine resistance in breast cancer

International Journal of Cancer, EarlyView.
Abstract Breast cancer patients who express estrogen receptor α (ER) typically receive endocrine therapy as a first‐line treatment. Most ER‐positive breast cancer patients initially respond to endocrine therapy, but up to 40% of patients develop resistance over time, and the main mechanism is aberrant activation of ER signaling pathways.
Wen Liu, Sahil Gupta, Sanjeev Gupta
wiley   +1 more source

Haemolytic anaemia due to metformin

, 2000
A S Kashyap, Shekhar Kashyap
openalex   +1 more source

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study [PDF]

, 2001
Charles J. Glueck, Harvey Phillips, Dan Cameron, Luann Sieve-Smith, Ping Wang   +4 more
openalex   +1 more source